Results 11 to 20 of about 261,882 (142)
Pentadecapeptide BPC 157 and the central nervous system [PDF]
Neural Regeneration Research, 2022 We reviewed the pleiotropic beneficial effects of the stable gastric pentadecapeptide BPC 157, three very recent demonstrations that may be essential in the gut-brain and brain-gut axis operation, and therapy application in the central nervous system ...
Jakša Vukojevic +11 more
doaj +5 more sources
Novelties regarding pentadecapeptide BPC-157
Biomedicine and surgery, 2021 Stable gastric pentadecapeptide BPC-157 is a novel anti-ulcer peptide, used in trials for the treatment of ulcerative colitis and now multiple sclerosis. That fifteen amino acid molecule is likely mediator of Robert’s stomach cytoprotection/adaptive cytoprotection and organoprotection, as well as a novel mediator of Selye’s stress coping response, to ...
Amić, Fedor +2 more
openaire +4 more sources
Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma [PDF]
Biomedicines, 2021 Cauterization of three episcleral veins (open-angle glaucoma model) induces venous congestion and increases intraocular pressure in rats. If not upgraded, one episcleral vein is regularly unable to acquire and take over the whole function, and glaucoma ...
Tamara Kralj +18 more
doaj +5 more sources
PENTADECAPEPTIDE BPC 157: PANACEA OR OVERHYPED PEPTIDE? [PDF]
European Journal of Physical Education and Sport Science<p>Interest in Pentadecapeptide BPC 157, an oligopeptide originally derived from human gastric juice, has grown substantially among members of the fitness community in the past few years due to its wide range of purported and previously reported effects on improving health and enhancing performance.
Joseph A. Giandonato, Victor Tringali
openaire +2 more sources
BPC-157 and the gut–brain axis: emerging links between cytoprotection and neuroregeneration
Annales Academiae Medicae SilesiensisIntroduction: The body protection compound-157 (BPC-157) peptide modulates the gut–brain axis (GBA), affecting neural and gastrointestinal functions.
Barbara Pietrzyk, Maciej Waluga
doaj +2 more sources
Pentadecapeptide BPC 157 and Rac 1 inhibitors [PDF]
, 2016 UVOD: Rac1 je mali signalizirajući G-protein koji može aktivirati NF-kappaB. Pentadekapeptid BPC 157 smanjuje transkripciju Vcam-1 u NF-kappaB signalnom putu kao i neki NF-kappaB inhibitori te suprimira da ERK inducira Vcam-1 preko NF-kappaB aktivacije.
Vidović, Tinka
core +2 more sources
Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle
Biomedicines, 2022 First, we review the definitively severed myotendinous junction and recovery by the cytoprotective stable gastric pentadecapeptide BPC 157 therapy, its healing that might combine both transected and detached tendon and transected muscle, ligament and ...
Mario Staresinic +24 more
doaj +6 more sources
Emergency Medicine International, 2020 Recently, the pentadecapeptide BPC 157-induced counteraction of bupivacaine cardiotoxicity has been reported. Medication includes (i) lidocaine-induced local anesthesia via intraplantar application and axillary and spinal (L4-L5) intrathecal block, (ii ...
Marin Lozic +16 more
doaj +1 more source
Gut and Liver, 2020 We reviewed again the significance of the stable gastric pentadecapeptide BPC 157 as a likely mediator of Robert’s stomach cytoprotection/adaptive cytoprotection and organoprotection and as novel mediator of Selye’s stress coping response to reestablish ...
Predrag Sikiric +11 more
doaj +1 more source
Molecular effects of stable gastric pentadecapeptide BPC 157 on psoriasis
Liječnički vjesnik, 2023 Psoriasis is a chronic, relapsing, immune-mediated skin disease. Etiopathogeniesis of psoriasis includes pro-inflammatory cytokines such as: TNF-alpha, IL-12, IL-17, IL-23 etc.
Hrvoje Vraneš +2 more
doaj +1 more source